2018 Cell Surface Marker Testing Market: Emerging Opportunities in the US, Europe (France, Germany, Italy, Spain, UK), Japan-Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

April 2018 | 120 pages | ID: 2E83B7C7537EN
Venture Planning Group

Abstracts

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 120 pages and 15 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Lymphocyte Subclassification CD4/CD8
  Instrumentation and Reagent Test Kits
    BD
    Beckman Coulter/Danaher
    T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
  1. Hematology Analyzers
    a. Overview
      Electrical Aperture-Impedance Analyzers
      Light Scatter Analyzers
    b. System Review
      Abbott
      Beckman Coulter/Danaher
      Biocode Hycel
      Drew-Scientific
      Horiba
      Menarini
      Nihon Kohden
      Siemens
      Sysmex
  2. Flow Cytometers
    a. Introduction
    b. System Overview
      Becton Dickinson
      Beckman Coulter/Danaher
E. Current Market Needs and Future Demand For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
  1. Information Technologies
  2. Automation and Robotics
  3. Lasers
  4. Artificial Intelligence
  5. Monoclonal Antibodies
  6. Molecular Diagnostics
  7. Microdrop Technology

III. FRANCE: FORECASTS BY TEST AND MARKET SEGMENT

IV. GERMANY: FORECASTS BY TEST AND MARKET SEGMENT

V. ITALY: FORECASTS BY TEST AND MARKET SEGMENT

VI. JAPAN: FORECASTS BY TEST AND MARKET SEGMENT

VII. SPAIN: FORECASTS BY TEST AND MARKET SEGMENT

VIII. U.K.: FORECASTS BY TEST AND MARKET SEGMENT

IX. U.S.: FORECASTS BY TEST AND MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
  1. Four Marketing Approaches
  2. Product Complexity Factor
  3. Customer Preference Factor
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation Factor

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Dako/Agilent Technologies
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex

XIII. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS

List Of Tables

LIST OF TABLES

France, Hospital Laboratories Estimated Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated Cell Surface Marker Test Volume